Journal of Virology · 2009 · 33 citations · 20 references
Life SciencesImmunologyInfectious DiseasesInflammationInnate ImmunityMolecular VirologyCytokine SignalingInflammatory SignalingInnate Immune ActivationInnate Immune Signaling PathwaysMacrophage BiologyViral PathogenesisCytokine Signaling In InfectionMacrophage Activation CytokinesMacrophage Activation SignalingMacrophage Cytokine ProductionMacrophage Inflammatory ResponsesMyeloid Cell ActivationProinflammatory Cytokine ModulationProtein Expression Levels
The M141 protein of myxoma virus (MYXV) is a viral CD200 homolog (also called vOX-2) that inhibits macrophage activation in infected rabbits. Here, we show that murine myeloid RAW 264.7 cells became activated when infected with MYXV in which the M141 gene was deleted (vMyx-M141KO) but not with the parental wild-type MYXV. Moreover, transcript and protein levels of tumor necrosis factor and granulocyte colony-stimulating factor were rapidly upregulated in an NF-kappaB-dependent fashion in the RAW 264.7 cells infected with vMyx-M141KO. M141 protein is present in the virion and counteracts this NF-kappaB activation pathway upon infection with the wild-type MYXV. Our data suggest that upregulation of these classic macrophage-related proinflammatory cytokine markers following infection of myeloid cells with the M141-knockout MYXV is mediated via the rapid activation of the cellular NF-kappaB pathway.
20
Cloning and Characterization of Inducible Nitric Oxide Synthase from Mouse Macrophages
Q W Xie, Hearn Jay Cho, Jimmy Calaycay et al. · Science · 1992 · 1.9K citations
The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation
Alexander Hoffmann, Andre Levchenko, Martin Scott et al. · Science · 2002 · 1.9K citations
Preparation of Cell Cultures and Vaccinia Virus Stocks
Patricia L. Earl, Norman S. Cooper, Linda S. Wyatt et al. · Current Protocols in Protein Science · 1998 · 287 citations